RUNX1 and acute myeloid leukemia: This protein is highly expressed in AML patients, where it suppresses miR-223 expression by methylating RUNX1 at arginine 223 residue, and thus determines the assembly of the double PHD fingers 2 (DPF2)-containing repressor complex on the MIR223 gene promoter.